Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-25
2007-12-25
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S309000
Reexamination Certificate
active
11375692
ABSTRACT:
Compounds are disclosed that have a formula represented by the following:The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
REFERENCES:
patent: 5756524 (1998-05-01), Riordan et al.
patent: 6013837 (2000-01-01), Demassey et al.
patent: 6794397 (2004-09-01), Cai et al.
patent: 2004/0048891 (2004-03-01), Kato et al.
patent: 2004/0116399 (2004-06-01), Zhu et al.
patent: 2004/0192728 (2004-09-01), Codd et al.
patent: 2005/0222200 (2005-10-01), Kelly
Michele C. Jetter, Mark A. Youngman, James J. McNally, Sui-Po Zhang, Adrienne E. Dubin, Nadia Nasserb and Scott L. Dax, N-Isoquinolin-5-yl-N0-aralkyl-urea and -amide antagonists of human vanilloid receptor 1 Bioorganic & Medicinal Chemistry Letters 2004, 14, 3053-3056.
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim Chapter 8, pp. 279-308.
Tafesh, Ahmed M.; Weiguny, Jens “A Review of the Selective Catalytic Reduction of Aromatic Nitro Compounds into Aromatic Amines, Isocyanates, Carbamates, and Ureas Using CO” Chem. Rev. 1996, 96, 2035-2052.
Fontani, Pierre; Carboni, Bertrand; Vaultier, Michel; Carrie, Robert “Convenient Highly Stereoselective Synthesis of Cyclopropylboronates” Tetrahedron Letters 1989, 30, 4815-4818.
Duncton Matthew
Janagani Satyanarayana
Kelly Michael G.
Kincaid John
Desai Rita
Klauber & Jackson LLC
O'Dell David K
Renovis, Inc.
LandOfFree
Amide derivatives as ion-channel ligands and pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amide derivatives as ion-channel ligands and pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amide derivatives as ion-channel ligands and pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3841727